223 related articles for article (PubMed ID: 16204043)
1. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
2. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
3. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice.
Karabinis ME; Larson D; Barlow C; Wynshaw-Boris A; Moser AR
Carcinogenesis; 2001 Feb; 22(2):343-6. PubMed ID: 11181458
[TBL] [Abstract][Full Text] [Related]
5. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
7. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ
Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946
[TBL] [Abstract][Full Text] [Related]
8. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
9. Combined haploinsufficiency for ATM and RAD9 as a factor in cell transformation, apoptosis, and DNA lesion repair dynamics.
Smilenov LB; Lieberman HB; Mitchell SA; Baker RA; Hopkins KM; Hall EJ
Cancer Res; 2005 Feb; 65(3):933-8. PubMed ID: 15705893
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
[TBL] [Abstract][Full Text] [Related]
11. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
12. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
Bennett LM; McAllister KA; Malphurs J; Ward T; Collins NK; Seely JC; Gowen LC; Koller BH; Davis BJ; Wiseman RW
Cancer Res; 2000 Jul; 60(13):3461-9. PubMed ID: 10910057
[TBL] [Abstract][Full Text] [Related]
13. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
[TBL] [Abstract][Full Text] [Related]
15. Effect of ATM heterozygosity on heritable DNA damage in mice following paternal F0 germline irradiation.
Baulch JE; Li MW; Raabe OG
Mutat Res; 2007 Mar; 616(1-2):34-45. PubMed ID: 17161850
[TBL] [Abstract][Full Text] [Related]
16. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
[TBL] [Abstract][Full Text] [Related]
19. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
Waddell N; Jonnalagadda J; Marsh A; Grist S; Jenkins M; Hobson K; Taylor M; Lindeman GJ; Tavtigian SV; Suthers G; Goldgar D; Oefner PJ; ; Taylor D; Grimmond S; Khanna KK; Chenevix-Trench G
Genes Chromosomes Cancer; 2006 Dec; 45(12):1169-81. PubMed ID: 17001622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
